• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激与糖尿病视网膜病变严重程度在 1 型和 2 型糖尿病中的作用。

Role of Oxidative Stress and Severity of Diabetic Retinopathy in Type 1 and Type 2 Diabetes.

机构信息

Department of Optometry and Vision Science, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

Department of Clinical Laboratory Sciences, Chair of Medical and Molecular Genetics, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

出版信息

Ophthalmic Res. 2021;64(4):613-621. doi: 10.1159/000514722. Epub 2021 Jan 26.

DOI:10.1159/000514722
PMID:33498043
Abstract

BACKGROUND

Diabetic retinopathy (DR) is a sight-threatening complication of diabetes mellitus (DM). Oxidative stress generated on account of hyperglycemic state may lead to retinal abnormalities including DR.

OBJECTIVES

The aim of the study was to evaluate the status of antioxidant enzymes; superoxide dismutase (SOD), and catalase (CAT), in different stages of DR severity in subjects with type 1 DM (T1DM) and type 2 DM (T2DM).

METHODS

The cross-sectional study enrolled 148 subjects with T1DM (n = 17), T2DM (n = 96), and nondiabetic controls (n = 35). Subjects with DM were divided into 2 subgroups based on DR severity (mild-to-severe nonproliferative DR [NPDR] and proliferative DR [PDR]), and serum glycated hemoglobin (HbA1c), lipid profile, SOD, and CAT were estimated.

RESULTS

Both SOD and CAT levels were lower in diabetic subjects than nondiabetic controls. A significant positive correlation was found between HbA1C level and severity of DR (p < 0.0001). Levels of SOD and CAT varied significantly with DR severity in both diabetic groups at p < 0.05. Furthermore, levels of SOD and CAT were found to decrease significantly (p < 0.001) in DR (+) compared to DR (-) patients. Also, increased levels of HbA1c were significantly associated (p < 0.001) with decreased SOD in both subgroups (NPDR and PDR). DR severity was significantly associated with SOD and CAT in the NPDR and PDR subgroups (p < 0.05).

CONCLUSION

Oxidative stress and decreased antioxidant defenses are associated with DR progression to its PDR stage.

摘要

背景

糖尿病视网膜病变(DR)是糖尿病(DM)的一种威胁视力的并发症。高血糖状态下产生的氧化应激可能导致包括 DR 在内的视网膜异常。

目的

本研究旨在评估 1 型糖尿病(T1DM)和 2 型糖尿病(T2DM)患者不同 DR 严重程度阶段的抗氧化酶超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的状态。

方法

这项横断面研究纳入了 148 名 T1DM 患者(n=17)、T2DM 患者(n=96)和非糖尿病对照者(n=35)。根据 DR 严重程度(轻度至重度非增殖性 DR [NPDR]和增殖性 DR [PDR])将 DM 患者分为 2 个亚组,并评估血清糖化血红蛋白(HbA1c)、血脂谱、SOD 和 CAT。

结果

与非糖尿病对照组相比,糖尿病患者的 SOD 和 CAT 水平均较低。HbA1C 水平与 DR 严重程度呈显著正相关(p<0.0001)。在两个糖尿病组中,SOD 和 CAT 水平随着 DR 严重程度的变化而显著变化(p<0.05)。此外,与 DR(-)患者相比,DR(+)患者的 SOD 和 CAT 水平显著降低(p<0.001)。此外,HbA1c 水平升高与两个亚组(NPDR 和 PDR)中 SOD 降低显著相关(p<0.001)。NPDR 和 PDR 亚组中,DR 严重程度与 SOD 和 CAT 显著相关(p<0.05)。

结论

氧化应激和抗氧化防御能力下降与 DR 进展为 PDR 阶段有关。

相似文献

1
Role of Oxidative Stress and Severity of Diabetic Retinopathy in Type 1 and Type 2 Diabetes.氧化应激与糖尿病视网膜病变严重程度在 1 型和 2 型糖尿病中的作用。
Ophthalmic Res. 2021;64(4):613-621. doi: 10.1159/000514722. Epub 2021 Jan 26.
2
Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.戊糖苷和N-羧甲基赖氨酸:2型糖尿病视网膜病变的生物标志物。
Eur J Ophthalmol. 2011 Jan-Feb;21(1):48-54. doi: 10.5301/ejo.2010.4447.
3
Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device.使用无散瞳、全视野闪烁视网膜电图记录设备对糖尿病患者进行糖尿病视网膜病变筛查。
Doc Ophthalmol. 2020 Jun;140(3):211-220. doi: 10.1007/s10633-019-09734-2. Epub 2019 Nov 12.
4
Oxidative Stress, Inflammatory, Angiogenic, and Apoptotic molecules in Proliferative Diabetic Retinopathy and Diabetic Macular Edema Patients.增生性糖尿病视网膜病变和糖尿病黄斑水肿患者的氧化应激、炎症、血管生成和细胞凋亡分子。
Int J Mol Sci. 2023 May 4;24(9):8227. doi: 10.3390/ijms24098227.
5
Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain).西班牙加泰罗尼亚地区2型糖尿病患者中,通过视网膜照片记录有糖尿病视网膜病变的个体的糖尿病视网膜病变患病率。
Br J Ophthalmol. 2015 Dec;99(12):1628-33. doi: 10.1136/bjophthalmol-2015-306683. Epub 2015 Jun 18.
6
Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.糖尿病视网膜病变病变分布与光学相干断层扫描血管造影扫描与糖尿病视网膜病变严重程度的相关性分析。
JAMA Ophthalmol. 2020 Dec 1;138(12):1291-1297. doi: 10.1001/jamaophthalmol.2020.4516.
7
Serum Extracellular Superoxide Dismutase Is Associated with Diabetic Retinopathy Stage in Chinese Patients with Type 2 Diabetes Mellitus.血清细胞外超氧化物歧化酶与中国 2 型糖尿病患者糖尿病视网膜病变分期相关。
Dis Markers. 2018 Apr 22;2018:8721379. doi: 10.1155/2018/8721379. eCollection 2018.
8
Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset type 1 and type 2 diabetes.亚洲印度裔早发型1型和2型糖尿病患者糖尿病视网膜病变的患病率及危险因素
J Diabetes Complications. 2014 May-Jun;28(3):291-7. doi: 10.1016/j.jdiacomp.2013.12.008. Epub 2014 Jan 6.
9
Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.血浆载脂蛋白预测 2 型糖尿病患者糖尿病视网膜病变的发生和严重程度。
Front Endocrinol (Lausanne). 2022 Jul 22;13:915575. doi: 10.3389/fendo.2022.915575. eCollection 2022.
10
[Association of choroidal thickness with diabetic retinopathy at different stages].[不同阶段糖尿病视网膜病变与脉络膜厚度的相关性]
Zhonghua Yi Xue Za Zhi. 2015 Aug 25;95(32):2584-8.

引用本文的文献

1
Systematic Inflammation and Oxidative Stress Elevation in Diabetic Retinopathy and Diabetic Patients with Macular Edema.糖尿病视网膜病变及糖尿病性黄斑水肿患者的系统性炎症与氧化应激升高
Int J Mol Sci. 2025 Apr 17;26(8):3810. doi: 10.3390/ijms26083810.
2
Carnosic acid attenuates diabetic retinopathy via the SIRT1 signaling pathway: neuroprotection and endothelial cell preservation.迷迭香酸通过SIRT1信号通路减轻糖尿病视网膜病变:神经保护和内皮细胞保护
Am J Transl Res. 2025 Mar 15;17(3):2293-2310. doi: 10.62347/FKNZ9461. eCollection 2025.
3
Modelling neurodegeneration and inflammation in early diabetic retinopathy using 3D human retinal organoids.
使用3D人视网膜类器官模拟早期糖尿病视网膜病变中的神经退行性变和炎症。
In Vitro Model. 2024 Mar 25;3(1):33-48. doi: 10.1007/s44164-024-00068-1. eCollection 2024 Feb.
4
Molecular and Cellular Mechanisms Involved in the Pathophysiology of Retinal Vascular Disease-Interplay Between Inflammation and Oxidative Stress.涉及视网膜血管疾病病理生理学的分子和细胞机制-炎症和氧化应激的相互作用。
Int J Mol Sci. 2024 Nov 4;25(21):11850. doi: 10.3390/ijms252111850.
5
Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer's Disease: The Potential Role of a Novel Nano-Compound-The Transdermal Glutathione-Cyclodextrin Complex.急性和长期新冠、糖尿病、心肌梗死及阿尔茨海默病的治疗:一种新型纳米化合物——经皮谷胱甘肽 - 环糊精复合物的潜在作用
Antioxidants (Basel). 2024 Sep 12;13(9):1106. doi: 10.3390/antiox13091106.
6
THE EFFECT OF THERAPY WITH INSULIN ANALOGUES (ASPART AND GLARGINE) ON OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS.胰岛素类似物(门冬胰岛素和甘精胰岛素)治疗对1型糖尿病患者氧化应激参数的影响
Acta Endocrinol (Buchar). 2023 Oct-Dec;19(4):463-470. doi: 10.4183/aeb.2023.463. Epub 2024 Jun 24.
7
Association of Glutathione Peroxidase 3 (GPx3) and miR-196a with Carbohydrate Metabolism Disorders in the Elderly.谷胱甘肽过氧化物酶 3 (GPx3) 和 miR-196a 与老年人糖代谢紊乱的关系。
Int J Mol Sci. 2024 May 15;25(10):5409. doi: 10.3390/ijms25105409.
8
Therapeutic Potential of Antioxidants and Hybrid TEMPOL Derivatives in Ocular Neurodegenerative Diseases: A Glimpse into the Future.抗氧化剂和杂化TEMPOL衍生物在眼部神经退行性疾病中的治疗潜力:展望未来
Biomedicines. 2023 Nov 1;11(11):2959. doi: 10.3390/biomedicines11112959.
9
Ginsenoside Rg1 Ameliorates Pancreatic Injuries via the AMPK/mTOR Pathway in vivo and in vitro.人参皂苷Rg1通过AMPK/mTOR途径在体内外改善胰腺损伤。
Diabetes Metab Syndr Obes. 2023 Mar 15;16:779-794. doi: 10.2147/DMSO.S401642. eCollection 2023.
10
The effect of sodium-glucose cotransporter 2 inhibitors on biomarkers of inflammation: A systematic review and meta-analysis of randomized controlled trials.钠-葡萄糖协同转运蛋白2抑制剂对炎症生物标志物的影响:一项随机对照试验的系统评价和荟萃分析
Front Pharmacol. 2022 Nov 11;13:1045235. doi: 10.3389/fphar.2022.1045235. eCollection 2022.